BiOAID's novel Butterfly KN95 adhesive filter can be added to any cloth mask for effective and lasting protection from sub-micron and airborne particulate including viruses, bacteria, smoke, and allergens. With care, the BiOAID filter can be used repeatedly and for as long as two weeks between changes.
California-based BiOAID in collaboration with U.S. Department of Energy’s Argonne National Laboratory has developed innovative filter media rated at > 95.5% effectiveness that is offered in two variations:
Through the use of alternative materials available in the U.S. supply chain, BiOAID offers cost comparable N95 and KN95 solutions using novel U.S.-developed and U.S.-based manufacturing processes with the added benefits of reusable components, a longer shelf life and reduced profile for storage.
BiOAID N95-grade surgical masks are washable and BiOAID KN95 adhesive filters offer limited reuse to advance innovation in respirator and surgical masks. Designed to reduce waste, cost, and supply chain interruptions, BiOAID’s patent-pending filter media advances filtration innovation in the following ways:
• Improved breathability
• Intelligibility of speech
• No fogging of eyewear
• Foldable for convenience
• 20-year shelf life — 15 years more than existing offerings
• Competitively priced with current disposable N95s and surgical masks
• Adaptability to existing masks
BiOAID was developed with leading U.S. physicians and scientists for the consumer and medical marketplaces and meets Nelson Laboratory Safety Testing Standards. BiOAID filter technology was co-invented with medical experts in infectious diseases, surgery, and internal medicine in conjunction with a public health expert. BiOAID filter media was developed for a range of populations — from healthcare providers, warfighters, and first responders, to the general public. It has been field-tested in surgical operating rooms and fit-tested in hospitals. BIOAID has completed and passed Nelson Laboratory safety tests on filtration and breathability and is awaiting NIOSH certification.
Designed, developed and manufactured in the U.S., BiOAID uses materials that are accessible and abundant in the domestic supply chain, which facilitates medium-term supply chain relief and long-term and sustainable solutions. BiOAID has invested nearly $1 million USD in private funding to develop and prototype the BiOAID with its expert design engineers at its light manufacturing facility in Santa Rosa, CA, expert material scientists at Argonne National Laboratory, and medical and health advisors. Full-scale manufacturing of the BiOAID will be in partnership with suppliers in Ohio and North Carolina.
About BiOAID, Inc.
During the pandemic, electric vehicle drivetrain maker Orbis® repurposed a portion of its light manufacturing facility in Santa Rosa, CA, to address the shortcomings of N95s, utilizing NIOSH-grade filtration measuring equipment and implementing ISO-9002 manufacturing methods and procedures.
BiOAID launched research and development in March 2020, and collaborated with preeminent institutions, medical doctors, and scientists. Innovations include a patent-pending reusable N95 filter that offers the promise of a cost basis equal to disposables.
BiOAID has shipped over 1,500 beta samples and filed seven provisional patents.
BiOAID was developed with active contributions by the following Advisory Board members:
Julie E. Mangino MD, FSHEA, FIDSA
Professor of Internal Medicine (Emeritus) Division of Infectious Diseases, The Ohio State University, Columbus, Ohio . Dr. Mangino has 25 years of experience in education, research, and clinical care with a focus on prevention of healthcare associated infections. Co-inventor of BiOAID.
Michael S. Firstenberg MD, FAIM, FACC
Director of Research and Special Projects for the William Novick Global Cardiac Alliance, Chair of The American College of Cardiology, Credentialing and Member Services, President-elect, The American College of Academic International Medicine Adjunct Faculty, College of Graduate Studies and Associate Professor of Surgery and Integrative Medicine, Northeast Ohio Medical University, Rootstown, Ohio. Co-inventor of BiOAID.
Phil Demokritou, PhD
Associate Professor at Harvard University’s School of PublicHealth, Director of the Environmental Health Nanoscience Laboratory / Harvard Center for Nanotechnology and Nanotoxicology. Prof Demokritou’s innovative nanoscience includes the development of antimicrobial intervention platforms for prevention of infectious diseases.
Research and Development
3200 Dutton Ave. Ste 424
Santa Rosa, CA 95407
475-B Miller Ave.
Mill Valley, CA 94941
Marcus Hays, CEO
BiOAID® © 2021
All rights reserved. BiOAID™ Butterfly KN95 Adhesive Filter, Patent-Pending.
orbisdriven.com | ORBIS®, Mill Valley, CA